Get the Stockscreener App
62.75
1.88%
-1.20
Livanova Plc stock is traded at $62.75, with a volume of 503.50K.
It is down -1.88% in the last 24 hours and up +10.83% over the past month.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
See More
Previous Close:
$63.95
Open:
$64.305
24h Volume:
503.50K
Relative Volume:
0.89
Market Cap:
$3.43B
Revenue:
$1.28B
Net Income/Loss:
$-222.15M
P/E Ratio:
-15.34
EPS:
-4.09
Net Cash Flow:
$145.52M
1W Performance:
-0.96%
1M Performance:
+10.83%
6M Performance:
+34.57%
1Y Performance:
+20.42%
1-Day Range:
$62.64
$64.35
1-Week Range:
$61.80
$65.57
52-Week Range:
$32.48
$65.57
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
62.75 | 3.49B | 1.28B | -222.15M | 145.52M | -4.09 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-25 | Downgrade | Goldman | Buy → Neutral |
| May-20-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Feb-26-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-04-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-14-23 | Initiated | Mizuho | Neutral |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Feb-24-22 | Upgrade | UBS | Neutral → Buy |
| Dec-03-21 | Initiated | Goldman | Buy |
| Aug-20-21 | Reiterated | Needham | Buy |
| Jul-20-21 | Upgrade | Needham | Hold → Buy |
| Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-05-21 | Downgrade | Needham | Buy → Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-26-20 | Reiterated | Needham | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-08-18 | Initiated | Stifel | Buy |
| May-31-18 | Reiterated | Needham | Buy |
| Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
What drives LivaNova PLC stock priceEarnings Call Summaries & Real-Life Case Studies You Can Follow - earlytimes.in
LivaNova PLC (NASDAQ:LIVN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
LivaNova’s Essenz Perfusion System, UK - Medical Device Network
LivaNova PLC $LIVN Holdings Reduced by Redmile Group LLC - MarketBeat
LivaNova to Present at Piper Sandler Healthcare Conference in December - MSN
LivaNova stock hits 52-week high at 64.46 USD - Investing.com
LivaNova (NASDAQ:LIVN) Hits New 52-Week HighHere's What Happened - MarketBeat
LivaNova (NASDAQ:LIVN) Reaches New 1-Year HighWhat's Next? - MarketBeat
Discipline and Rules-Based Execution in LIVN Response - news.stocktradersdaily.com
The Bull Case For LivaNova (LIVN) Could Change Following Medicare VNS Boost And New OSA Leader - simplywall.st
Marshall Wace LLP Has $36.68 Million Stake in LivaNova PLC $LIVN - MarketBeat
30,600 Shares in LivaNova PLC $LIVN Purchased by Quantbot Technologies LP - MarketBeat
New York State Common Retirement Fund Purchases 38,451 Shares of LivaNova PLC $LIVN - MarketBeat
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea - MSN
Improved Revenues Required Before LivaNova PLC (NASDAQ:LIVN) Stock's 26% Jump Looks Justified - simplywall.st
LivaNova PLC $LIVN Shares Sold by Kennedy Capital Management LLC - MarketBeat
Legal & General Group Plc Has $4.09 Million Stake in LivaNova PLC $LIVN - MarketBeat
LivaNova (NASDAQ:LIVN) Downgraded by Wall Street Zen to Buy - MarketBeat
LivaNova (LIVN): Assessing Valuation After CMS Boosts Reimbursement for VNS Therapy Procedures - Sahm
Why institutional investors increase stakes in LivaNova PLC (LIA) stockQuarterly Market Summary & Daily Stock Trend Watchlist - Newser
Prudential Financial Inc. Sells 71,065 Shares of LivaNova PLC $LIVN - MarketBeat
Will LivaNova PLC stock gain from strong economyWeekly Trade Recap & Verified Momentum Watchlists - Newser
How LivaNova PLC (LIA) stock reacts to fiscal policiesDividend Hike & Stepwise Trade Execution Plans - Newser
LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting - facilitiesmanagement-now.com
LivaNova (Nasdaq: LIVN) to present CORE-VNS seizure and cost data at AES 2025 - Stock Titan
LivaNova appoints Lucile Blaise to lead sleep apnea commercialization By Investing.com - Investing.com Australia
LivaNova stock hits 52-week high at 64.1 USD - Investing.com India
LivaNova stock hits 52-week high at 64.1 USD By Investing.com - Investing.com South Africa
LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025 - marketscreener.com
LivaNova appoints Lucile Blaise to lead sleep apnea commercialization - Investing.com India
Livanova appoints Lucile Blaise as global head of commercialization, obstructive sleep apnea - marketscreener.com
LivaNova names Lucile Blaise global head of sleep apnea unit - StreetInsider
LivaNova PLC $LIVN Shares Acquired by Capital Fund Management S.A. - MarketBeat
Why LivaNova PLC (LIA) stock remains top ratedJuly 2025 Short Interest & Weekly Stock Performance Updates - Newser
Is LivaNova PLC (LIA) stock a buy before new product rolloutJuly 2025 Spike Watch & Long-Term Investment Growth Plans - Newser
Creative Planning Buys New Shares in LivaNova PLC $LIVN - MarketBeat
LivaNova (LIVN) Is Up 5.5% After Medicare Boosts VNS Therapy Reimbursement—Has the Bull Case Changed? - simplywall.st
F m Investments LLC Raises Stake in LivaNova PLC $LIVN - MarketBeat
Is LivaNova PLC stock attractive for income investorsPortfolio Gains Report & Weekly Hot Stock Watchlists - BỘ NỘI VỤ
Behavioral Patterns of LIVN and Institutional Flows - news.stocktradersdaily.com
Paradice Investment Management LLC Raises Stake in LivaNova PLC $LIVN - MarketBeat
A Look at LivaNova's (LIVN) Valuation Following Its Recent 20% Share Price Surge - Yahoo Finance UK
North America Heart Pump Device Market Forecast and Company Analysis Report 2025-2033 Featuring Abbott, Getinge, Teleflex, Fresenius, LivaNova, CorWave, JARVIK HEART, ABIOMED - Yahoo Finance
FOMO Trade: How buybacks impact LivaNova PLC stock value2025 Performance Recap & Long-Term Investment Growth Plans - moha.gov.vn
LivaNova PLC $LIVN Shares Sold by Envestnet Asset Management Inc. - MarketBeat
Is LivaNova PLC (LIA) stock prepared for digital transitionJuly 2025 Final Week & Daily Stock Trend Watchlist - BỘ NỘI VỤ
Perfusion Systems Market Set to Witness Significant Growth - openPR.com
Dynamic Technology Lab Private Ltd Has $479,000 Stake in LivaNova PLC $LIVN - MarketBeat
LivaNova PLC (LIVN) Stock Forecasts - Yahoo Finance
Heater-Cooler Devices: Side Effects, Recalls & Lawsuit Information - Drugwatch.com
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):